Literature DB >> 10831

Suppression of the lytic and bactericidal effects of cell wallinhibitory antibiotics.

R Lopez, C Ronda-Lain, A Tapia, S B Waks, A Tomasz.   

Abstract

The bacteriolytic effect of beta-lactam antibiotics on Bacillus subtilis and on Streptococcus pneumoniae was found to be a function of the pH; lysis was suppressed if the pH of the pneumococcal culture was below 6.0 during penicillin treatment. In the case of B. subtilis, growth at pH 6.6 prevented penicillin-induced lysis. In pneumococci, the addition of trypsin to the growth medium also protected against lysis. The pH-dependent protection phenomenon resembled in several respects the antibiotic "tolerance" of pneumococci with a defective autolytic system. (i) At the pH nonpermissive for lysis, the bacteria retained their normal sensitivity to beta-lactam and to other cell wall inhibitors; however, instead of lysis, the drug-treated bacteria simply stopped growing. Loss of viability of the cells was also greatly reduced. (ii) Protection against lysis was independent of the dose and chemical nature of the cell wall inhibitors. (iii) The protection effect was reversible; lysis and loss of viability could be triggered by a postincubation of the drug-treated bacteria at the pH permissive for lysis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10831      PMCID: PMC429817          DOI: 10.1128/AAC.10.4.697

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  [ON THE MECHANISM OF ACTION OF PENICILLIN. I. ISOLATION AND CHARACTERIZATION OF PEPTIDES CONTAINING LOW MOLECULAR 2,6-DIAMINOPIMELIC ACID FROM PENICILLIN SPHEROPLASTS OF ESCHERICHIA COLI B].

Authors:  U SCHWARZ; W WEIDEL
Journal:  Z Naturforsch B       Date:  1965-02       Impact factor: 1.047

2.  A study of the genetic material determining an enzyme in Pneumococcus.

Authors:  S LACKS; R D HOTCHKISS
Journal:  Biochim Biophys Acta       Date:  1960-04-22

3.  Induction of bacterial lysis by penicillin.

Authors:  L S PRESTIDGE; A B PARDEE
Journal:  J Bacteriol       Date:  1957-07       Impact factor: 3.490

4.  Protoplasts and L-type growth of Escherichia coli.

Authors:  J LEDERBERG; J ST CLAIR
Journal:  J Bacteriol       Date:  1958-02       Impact factor: 3.490

5.  REQUIREMENTS FOR TRANSFORMATION IN BACILLUS SUBTILIS.

Authors:  C Anagnostopoulos; J Spizizen
Journal:  J Bacteriol       Date:  1961-05       Impact factor: 3.490

6.  Enzyme replacement in a bacterium: phenotypic correction by the experimental introduction of the wild type enzyme into a live enzyme defective mutant pneumococcus.

Authors:  A Tomasz; S Waks
Journal:  Biochem Biophys Res Commun       Date:  1975-08-18       Impact factor: 3.575

7.  Cellular metabolism in genetic transformation of pneumococci: requirement for protein synthesis during induction of competence.

Authors:  A Tomasz
Journal:  J Bacteriol       Date:  1970-03       Impact factor: 3.490

8.  Biological consequences of the replacement of choline by ethanolamine in the cell wall of Pneumococcus: chanin formation, loss of transformability, and loss of autolysis.

Authors:  A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

Review 9.  The barrier function of the gram-negative envelope.

Authors:  L Leive
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

10.  The role of autolysins in cell death.

Authors:  A Tomasz
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

View more
  24 in total

1.  Two bactericidal targets for penicillin in pneumococci: autolysis-dependent and autolysis-independent killing mechanisms.

Authors:  P Moreillon; Z Markiewicz; S Nachman; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

2.  Tolerant response of Streptococcus sanguis to beta-lactams and other cell wall inhibitors.

Authors:  D Horne; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

3.  Absence of spontaneous autolysis of Streptococcus pneumoniae in aerobic fan culture bottles in a commercial blood culture system.

Authors:  A Casetta; V Derouin; Y Boussougant
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

4.  Peptidoglycan synthesis in cocci and rods of a pH-dependent, morphologically conditional mutant of Klebsiella pneumoniae.

Authors:  G Satta; R Fontana; P Canepari; G Botta
Journal:  J Bacteriol       Date:  1979-02       Impact factor: 3.490

5.  Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion.

Authors:  Miriam Moscoso; Ernesto García; Rubens López
Journal:  J Bacteriol       Date:  2006-08-25       Impact factor: 3.490

6.  Cell envelope of Neisseria gonorrhoeae: penicillin enhancement of peptidoglycan hydrolysis.

Authors:  W S Wegener; B H Hebeler; S A Morse
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

7.  Characterization of cell wall polymers secreted into the growth medium of lysis-defective pneumococci during treatment with penicillin and other inhibitors of cell wall synthesis.

Authors:  R Hakenbeck; S Waks; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

8.  Secretion of lipids induced by inhibition of peptidoglycan synthesis in streptococci.

Authors:  D Horne; R Hakenbeck; A Tomasz
Journal:  J Bacteriol       Date:  1977-11       Impact factor: 3.490

9.  Secretion of cell wall polymers into the growth medium of lysis-defective pneumococci during treatment with penicillin and other inhibitors of cell wall synthesis.

Authors:  S Waks; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

10.  pH-dependent penicillin tolerance may protect intraleukocytic Staphylococcus aureus from killing by cloxacillin.

Authors:  N Craven; J C Anderson
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.